Three-plane CCI comparable with single-plane outcomes

Article

The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.

The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.

Dr Marco Lombardo et al., Fondazione G.B. Bietti IRCCS, Rome, Italy, performed inflation testing in 14 human eye globes to assess the topographic response to the cornea to CCIs.

The eyes were divided into two group, with first group undergoing a 2.75 mm three-plane CCI created with an FS laser and the control group receiving a 2.75 mm manual CCI using disposable angled knives.

A Scheimpflug topographer was used to obtain topographic maps of the anterior and posterior cornea, keratometric data was used to evaluate the curvature changes of the cornea and vector analysis was used to identify the changes of corneal astigmatism.

The mean postoperative change of the anterior keratometric power was 0.04 ± 0.39 and 0.05 ± 0.51 in the FS laser and control groups, respectively and the mean change of the posterior corneal keratometric power was 0.16 ± 0.19 and 0.15 ± 0.18 D, respectively.

It was found that the average change of the anterior and posterior corneal astigmatism vector magnitude was 0.17 D or less in both groups. The team also recorded an insignificant against-the-rule astigmatic change in the anterior and posterior corneal interfaces after both CCI techniques.

To read the abstract please visit the Journal of Refractive Surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.